Lee Yong Lim

11.7k total citations · 2 hit papers
182 papers, 9.1k citations indexed

About

Lee Yong Lim is a scholar working on Molecular Biology, Biomaterials and Pharmaceutical Science. According to data from OpenAlex, Lee Yong Lim has authored 182 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 41 papers in Biomaterials and 30 papers in Pharmaceutical Science. Recurrent topics in Lee Yong Lim's work include Bee Products Chemical Analysis (29 papers), Advanced Drug Delivery Systems (26 papers) and Insect and Pesticide Research (21 papers). Lee Yong Lim is often cited by papers focused on Bee Products Chemical Analysis (29 papers), Advanced Drug Delivery Systems (26 papers) and Insect and Pesticide Research (21 papers). Lee Yong Lim collaborates with scholars based in Australia, Singapore and China. Lee Yong Lim's co-authors include Eugene Khor, Min Huang, Zengshuan Ma, Cornelia Locher, Shu‐Feng Zhou, Lucy S.C. Wan, Aileen Wee, Balram Chowbay, Yun Mo and Lishan Wang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biomaterials.

In The Last Decade

Lee Yong Lim

175 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Implantable applications of chitin and chitosan

2003 1.2k citations Lee Yong Lim et al. profile →
Uptake and Cytotoxicity of Chitosan Molecules and Nanoparticles: Effects of Molecular Weight and Degree of Deacetylation

2004 679 citations Lee Yong Lim et al. profile →

Peers

Countries citing papers authored by Lee Yong Lim

Since Specialization

Citations

This map shows the geographic impact of Lee Yong Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Yong Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Yong Lim more than expected).

Fields of papers citing papers by Lee Yong Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee Yong Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Yong Lim. The network helps show where Lee Yong Lim may publish in the future.

Co-authorship network of co-authors of Lee Yong Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Lee Yong Lim. A scholar is included among the top collaborators of Lee Yong Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee Yong Lim. Lee Yong Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and Validation of a Stability-Indicating HPTLC-Based Assay for the Quantification of Nitrofurazone Ointment 2025 ·Molecules ·(unknown), H. A. Andrews, (unknown), (unknown), (unknown), Tomislav Sostaric, Lee Yong Lim, (unknown), Cornelia Locher	0
2	Net Promoter Score Model for Evaluating Paediatric Medicine Acceptability: Validation and Feasibility Study 2024 ·Pharmaceutics ·(unknown), (unknown), Britta S. von Ungern‐Sternberg, Lee Yong Lim	0
3	Edaravone for the Treatment of Motor Neurone Disease: A Critical Review of Approved and Alternative Formulations against a Proposed Quality Target Product Profile 2024 ·Pharmaceutics ·(unknown), (unknown), Philip Burcham, Lee Yong Lim	2
4	In Vitro Assessment of Wound-Healing Efficacy of Stabilized Basic Fibroblast Growth Factor (FGF-2) Solutions 2024 ·Pharmaceuticals ·(unknown), Jingxin Mo, Mingxin Li, Gunesh P. Rajan, Cornelia Locher, Lee Yong Lim	1
5	The Development of a Chocolate-Based Chewable Tablet of Prednisolone—Enhancing the Palatability of Steroids for Pediatric Use 2024 ·Pharmaceutics ·(unknown), Edith K. Y. Tang, Md. Lokman Hossain, Britta S. von Ungern‐Sternberg, David Sommerfield, Chloe Heath, (unknown), R. Nazim Khan, Cornelia Locher, Minh N. Nguyen, Lee Yong Lim	1
6	Peripheral T-cell receptor repertoire dynamics in small cell lung cancer 2023 ·Translational Lung Cancer Research ·(unknown), Margaret L. Axelrod, Justin M. Balko, Armand Bankhead, Tristan Shaffer, Lee Yong Lim, Jiannan Guo, Jennifer Hernandez, Mark Li, Wade T. Iams	3
7	Application of a Customised Franz-Type Cell Coupled with HPTLC to Monitor the Timed Release of Bioactive Components in Complex Honey Matrices 2023 ·Methods and Protocols ·Md. Lokman Hossain, Minh N. Nguyen, (unknown), Lee Yong Lim, Katherine A. Hammer, D.S. Hettiarachchi, Cornelia Locher	2
8	Evaluation of Ground and Surface Water Hydrochemistry for Irrigation Suitability in Borneo: Insights from Brunei Darussalam 2023 ·Water ·(unknown), (unknown), Lee Yong Lim, (unknown), Mario Schirmer, Stefan Gödeke	5
9	Paediatric Medicinal Formulation Development: Utilising Human Taste Panels and Incorporating Their Data into Machine Learning Training 2023 ·Pharmaceutics ·(unknown), Britta S. von Ungern‐Sternberg, Lee Yong Lim	4
10	Taste-Masked Flucloxacillin Powder Part 2: Formulation Optimisation Using the Mixture Design Approach and Storage Stability 2023 ·Pharmaceuticals ·(unknown), Sam Salman, Britta S. von Ungern‐Sternberg, Lee Yong Lim	0
11	Upconversion Nanoparticle-Based Cell Membrane-Coated cRGD Peptide Bioorthogonally Labeled Nanoplatform for Glioblastoma Treatment 2022 ·ACS Applied Materials & Interfaces ·Jingxin Mo, Xianjue Chen, Meiying Li, (unknown), Wei Zhao, Lee Yong Lim, Richard D. Tilley, J. Justin Gooding, Qinghua Li	22
12	A Comprehensive Survey of Phenolic Constituents Reported in Monofloral Honeys around the Globe 2022 ·Foods ·Ivan Lozada Lawag, Lee Yong Lim, (unknown), Katherine A. Hammer, Cornelia Locher	27
13	Development of an Add-On Device Using 3D Printing for the Enhancement of Drug Administration Efficiency of Dry Powder Inhalers (Accuhaler) 2022 ·Pharmaceutics ·(unknown), Lee Yong Lim, Inderbir Singh, Pornsak Sriamornsak, Thanongsak Thepsonthi, Kampanart Huanbutta, Tanikan Sangnim	5
14	Stabilisation of Recombinant Human Basic Fibroblast Growth Factor (FGF-2) against Stressors Encountered in Medicinal Product Processing and Evaluation 2021 ·Pharmaceutics ·(unknown), Gunesh P. Rajan, Cornelia Locher, Lee Yong Lim	11
15	Colloidal Polymeric Platform for Facile Click-Assisted Ligand Functionalization and Receptor Targeting 2016 ·ACS Omega ·Ruhani Singh, Diwei Ho, Lee Yong Lim, K. Swaminathan Iyer, Nicole M. Smith	4
16	Shear induced carboplatin binding within the cavity of a phospholipid mimic for increased anticancer efficacy 2015 ·Scientific Reports ·Jingxin Mo, Paul K. Eggers, Xianjue Chen, (unknown), Thomas Becker, Lee Yong Lim, Colin L. Raston	34
17	Uptake and cytotoxicity of chitosan nanoparticles in human liver cells 2010 ·Toxicology and Applied Pharmacology ·(unknown), George C. Yeoh, Martin Saunders, Lee Yong Lim	113
18	Potential for Scaled-up Manufacture of Chitosan Nanoparticles Using the Spinning Disc Processor 2008 ·UWA Profiles and Research Repository (UWA) ·(unknown), Martin Saunders, Lee Yong Lim	1
19	Stability of cefazolin sodium eye drops 1998 ·Journal of Clinical Pharmacy and Therapeutics ·(unknown), (unknown), (unknown), Lee Yong Lim, (unknown), Paul C. Ho, Sui Yung Chan	11
20	Anticholinesterase activity of 4-aminoquinolines related to amodiaquine and their respective N-oxides 1986 ·Mei‐Lin Go, (unknown), Lee Yong Lim	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact